• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丝氨酸蛋白酶抑制剂的抑制机制。涉及蛋白酶活性位点丝氨酸残基的步骤鉴定。

Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.

作者信息

Stone S R, Le Bonniec B F

机构信息

Department of Haematology, University of Cambridge, MRC Centre, UK.

出版信息

J Mol Biol. 1997 Jan 24;265(3):344-62. doi: 10.1006/jmbi.1996.0727.

DOI:10.1006/jmbi.1996.0727
PMID:9018048
Abstract

The role of the protease active-site serine residue in the formation of protease-serpin complexes has been investigated by using a mutant of thrombin in which Ser195 was mutated to alanine (S195A). The structural integrity of S195A was established by examining the kinetics of its interaction with the inhibitor hirudin, which does not have substantial interactions with Ser195. The affinity of S195A for hirudin was only tenfold less than that of thrombin and the kinetic constants for the formation of the S195A-hirudin complex were very similar to those observed with thrombin. In contrast to hirudin, the dissociation constants (Ki) for S195A with serpins (antithrombin, protease nexin-1 and alpha1-antitrypsin with a P1 arginine) were 2 x 10(3) to 2 x 10(5)-fold higher than those observed with thrombin. These results indicate a critical role for interactions with Ser195 in stabilizing the thrombin-serpin complexes. The cofactor heparin compensated partially for the loss of interactions with Ser195; it increased the affinity of S195A for protease nexin-1 and antithrombin by 140-fold and 1000-fold, respectively. In the case of heparin/antithrombin, the increase in affinity could be attributed mainly to interactions outside the active site of S195A. Kinetic studies with antithrombin and protease nexin-1 in the presence of heparin indicated that Ser195 was not involved in any rate-limiting process in the formation of protease-serpin complexes. Interactions with Ser195 increased the stability of the complex by markedly reducing its rate of breakdown rather than by increasing its rate of formation. Overall, the results of the kinetic studies were consistent with a mechanism in which the binding of the protease induces a rate-limiting conformational change in the serpin and interactions with the protease's active-site serine residue, occurring in a subsequent faster step, greatly stabilize the complex.

摘要

通过使用将丝氨酸195(Ser195)突变为丙氨酸的凝血酶突变体(S195A),研究了蛋白酶活性位点丝氨酸残基在蛋白酶-丝氨酸蛋白酶抑制剂复合物形成中的作用。通过检测其与水蛭素(与Ser195没有实质性相互作用)相互作用的动力学,确定了S195A的结构完整性。S195A与水蛭素的亲和力仅比凝血酶低10倍,并且形成S195A-水蛭素复合物的动力学常数与凝血酶观察到的非常相似。与水蛭素相反,S195A与丝氨酸蛋白酶抑制剂(抗凝血酶、蛋白酶连接蛋白-1和具有P1精氨酸的α1-抗胰蛋白酶)的解离常数(Ki)比凝血酶观察到的高2×10³至2×10⁵倍。这些结果表明与Ser195的相互作用在稳定凝血酶-丝氨酸蛋白酶抑制剂复合物中起关键作用。辅因子肝素部分补偿了与Ser195相互作用的丧失;它分别将S195A对蛋白酶连接蛋白-1和抗凝血酶的亲和力提高了140倍和1000倍。在肝素/抗凝血酶的情况下,亲和力的增加主要可归因于S195A活性位点之外的相互作用。在肝素存在下对抗凝血酶和蛋白酶连接蛋白-1进行的动力学研究表明,Ser195不参与蛋白酶-丝氨酸蛋白酶抑制剂复合物形成中的任何限速过程。与Ser195的相互作用通过显著降低复合物的分解速率而不是增加其形成速率来提高复合物的稳定性。总体而言,动力学研究结果与一种机制一致,即蛋白酶的结合在丝氨酸蛋白酶抑制剂中诱导限速构象变化,并且在随后更快的步骤中与蛋白酶活性位点丝氨酸残基的相互作用极大地稳定了复合物。

相似文献

1
Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.丝氨酸蛋白酶抑制剂的抑制机制。涉及蛋白酶活性位点丝氨酸残基的步骤鉴定。
J Mol Biol. 1997 Jan 24;265(3):344-62. doi: 10.1006/jmbi.1996.0727.
2
Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met-->Arg)-thrombin, alpha 1-antitrypsin (358Met-->Arg)-trypsin, and antitrypsin-elastase.丝氨酸蛋白酶抑制剂-蛋白酶复合物的建模:抗凝血酶-凝血酶、α1-抗胰蛋白酶(358位甲硫氨酸→精氨酸)-凝血酶、α1-抗胰蛋白酶(358位甲硫氨酸→精氨酸)-胰蛋白酶以及抗胰蛋白酶-弹性蛋白酶。
Proteins. 1996 Nov;26(3):288-303. doi: 10.1002/(SICI)1097-0134(199611)26:3<288::AID-PROT5>3.0.CO;2-A.
3
Mechanism of heparin activation of antithrombin: evidence for an induced-fit model of allosteric activation involving two interaction subsites.肝素激活抗凝血酶的机制:支持变构激活诱导契合模型的证据,该模型涉及两个相互作用亚位点。
Biochemistry. 1998 Sep 15;37(37):13033-41. doi: 10.1021/bi981426h.
4
Role of Leu99 of thrombin in determining the P2 specificity of serpins.凝血酶的亮氨酸99在决定丝氨酸蛋白酶抑制剂P2特异性中的作用。
Biochemistry. 1997 Jun 17;36(24):7437-46. doi: 10.1021/bi962965u.
5
Role of the P2 residue in determining the specificity of serpins.P2残基在决定丝氨酸蛋白酶抑制剂特异性中的作用。
Biochemistry. 1996 Sep 3;35(35):11461-9. doi: 10.1021/bi952717i.
6
The role of Arg46 and Arg47 of antithrombin in heparin binding.抗凝血酶的精氨酸46和精氨酸47在肝素结合中的作用。
Biochemistry. 1999 Aug 3;38(31):10196-204. doi: 10.1021/bi990686b.
7
The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.组织型纤溶酶原激活物的可变区-1通过促进催化作用赋予纤溶酶原激活物抑制剂-1对凝血酶的特异性:由异源蛋白质表面环解除动力学阻滞。
J Mol Biol. 1999 Oct 29;293(3):613-27. doi: 10.1006/jmbi.1999.3178.
8
Full or partial substitution of the reactive center loop of alpha-1-proteinase inhibitor by that of heparin cofactor II: P1 Arg is required for maximal thrombin inhibition.用肝素辅因子II的反应中心环完全或部分替代α-1-蛋白酶抑制剂的反应中心环:最大程度抑制凝血酶需要P1精氨酸。
Biochemistry. 2004 Nov 23;43(46):14864-72. doi: 10.1021/bi048833f.
9
Inhibitory mechanism of serpins. Interaction of thrombin with antithrombin and protease nexin 1.丝氨酸蛋白酶抑制剂的抑制机制。凝血酶与抗凝血酶及蛋白酶连接蛋白1的相互作用。
Biochemistry. 1995 Apr 18;34(15):5164-72. doi: 10.1021/bi00015a030.
10
Role of thrombin anion-binding exosite-I in the formation of thrombin-serpin complexes.凝血酶阴离子结合外位点-I在凝血酶-丝氨酸蛋白酶抑制剂复合物形成中的作用。
J Biol Chem. 1998 Nov 20;273(47):31203-8. doi: 10.1074/jbc.273.47.31203.

引用本文的文献

1
Conformational selection or induced fit? A critical appraisal of the kinetic mechanism.构象选择还是诱导契合?对动力学机制的批判性评价。
Biochemistry. 2012 Jul 31;51(30):5894-902. doi: 10.1021/bi3006913. Epub 2012 Jul 16.
2
Detection of serine proteases in extracts of the domestic mite Blomia tropicalis.热带屋尘螨提取物中丝氨酸蛋白酶的检测
Exp Appl Acarol. 2002;26(1-2):87-100. doi: 10.1023/a:1020931221953.
3
Dose-effect relationship for several coagulation markers during administration of the direct thrombin inhibitor S 18326 in healthy subjects.
健康受试者使用直接凝血酶抑制剂S 18326期间几种凝血标志物的剂量-效应关系。
Br J Clin Pharmacol. 2002 Feb;53(2):147-54. doi: 10.1046/j.0306-5251.2001.01534.x.
4
The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.Cβ-折叠片层的1链在α1-抗胰蛋白酶的结构和功能中的作用
Protein Sci. 2001 Dec;10(12):2518-24. doi: 10.1110/ps.ps.24101.
5
Structure of a serpin-enzyme complex probed by cysteine substitutions and fluorescence spectroscopy.通过半胱氨酸取代和荧光光谱法探测的丝氨酸蛋白酶抑制剂-酶复合物的结构
Biophys J. 2001 Jan;80(1):491-7. doi: 10.1016/S0006-3495(01)76031-6.